Sector valuations Intellia Therapeutics, Inc.
Equities
NTLA
US45826J1051
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.49 USD | -2.46% |
|
+2.74% | +50.06% |
| Mar. 06 | Nektar Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) | RE |
| Mar. 03 | Intellia Therapeutics Presents Longer-Term Clinical Data For Lonvoguran Ziclumeran | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -3.79x | 3.55x | 0.57x | 22.74x | -3.04x | -3x | -.--% | 1.59B | |
| 31.36x | 3.65x | 1.45x | 5.5x | 16.96x | 23.9x | 1.05% | 45.62B | |
| 55.97x | 7.2x | 0.47x | 4.84x | 32.49x | 40.97x | -.--% | 34.34B | |
| 33.29x | 2.42x | 1.16x | 8.54x | 21.97x | 26.44x | 0.37% | 29.46B | |
| 20.7x | 3.72x | 6.62x | 2.38x | 10.27x | 15.65x | -.--% | 28.09B | |
| -12.57x | 17.05x | -0.43x | 326.75x | -10.64x | -10.55x | -.--% | 19.11B | |
| 49.09x | 164.39x | -0.23x | 8.71x | 27.18x | 37.46x | -.--% | 14.78B | |
| 28.84x | 14.69x | 2.4x | 4.66x | 21.22x | 22.22x | -.--% | 14.09B | |
| 21.62x | 2.36x | 0.65x | 1.91x | 8.39x | 13.09x | 1.17% | 13.25B | |
| -18.38x | -51.14x | -0.26x | 14.53x | -20.1x | -18.69x | -.--% | 12.42B | |
| -30.23x | 39.89x | 1.16x | 3097.13x | -33.94x | -30.33x | -.--% | 10.03B | |
| -21.1x | 7.83x | -1.9x | 1285.06x | -17.65x | -17.45x | -.--% | 8.8B | |
| 44.2x | 4.01x | 0.26x | 7.07x | 19.78x | 21.75x | 0.58% | 8.69B | |
| 25.51x | 2.44x | -0.08x | 2.71x | 10.63x | 13.67x | -.--% | 8.65B | |
| 18.45x | 2.23x | 1.3x | 4.08x | 10.98x | 13.83x | 0.33% | 8.46B | |
| 16.56x | 0.88x | -0.51x | 1.37x | 7.01x | 7.75x | -.--% | 8.16B | |
| -26.86x | 18.13x | -2.01x | 5.23x | 128.84x | -252.61x | -.--% | 7.7B | |
| 27.25x | 3.22x | 1.27x | 3.39x | 13.99x | 20.45x | 0.82% | 7.68B | |
| -22.76x | 6.29x | -18.21x | 144.95x | -16.19x | -14.63x | -.--% | 6.94B | |
| Average | 12.48x | 13.31x | -0.33x | 260.61x | 12.01x | -4.74x | 0.23% | 15.15B | |
| Weighted average by Cap. | 21.22x | 12.90x | 0.70x | 177.16x | 14.19x | 8.54x | 0.31% |
- Stock Market
- Equities
- NTLA Stock
- Sector Intellia Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
